CPWM LLC’s Anixa Biosciences ANIX Stock Holding History

CPWM LLC’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20,000	Closed	-$61K	–	338
2022 Q2	$61K	Buy	+20,000	New	+$63.1K	0.01%	366

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CPWM LLC's ANIX Position: Q3 2022 in Review

CPWM LLC sold out of Anixa Biosciences (ANIX) in Q3 2022, closing a stake of 20,000 shares — an estimated $61K sold.

CPWM LLC first reported a position in ANIX in Q2 2022 and held it in 1 quarter. The position peaked at $61K in Q2 2022. 41 funds tracked by Wall St. Rank hold ANIX as of Q3 2022.

CPWM LLC reported no remaining Anixa Biosciences position as of Q3 2022 after selling out during the quarter.
CPWM LLC sold 20,000 Anixa Biosciences shares in Q3 2022, an estimated $61K.
CPWM LLC first reported a position in Anixa Biosciences in Q2 2022 and held it in 1 quarter.
CPWM LLC's Anixa Biosciences position peaked at $61K in Q2 2022.
41 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2022.

Based on CPWM LLC's 13F filing for Q3 2022, filed 14 Nov 2022.